Gut Virome in Health and Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 116
Special Issue Editor
2. System Microbiology and Antimicrobial Resistance (SMART) Lab, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong 999077, China
3. Microbiota I-Center (MagIC), Hong Kong 999077, China
Interests: microbiome; metagenomics; virome; early-life gut microbiome; host–microbiome interactions; bioinformatics
Special Issue Information
Dear Colleagues,
The gut virome, comprising viral components primarily composed of bacteriophages (phages) and human viruses, plays a crucial role in maintaining intestinal homeostasis and interacts dynamically with other microbiota components and the host. However, the majority of viral entities in the gut, often referred to as "dark matter", remain poorly understood in terms of their functions and roles in health and disease. Furthermore, the potential of phage therapy as an alternative to antibiotics requires further investigation to establish its efficacy and safety.
This Special Issue aims to present recent advances in understanding the significance of the gut virome in health and disease. We invite the submission of reviews and original research articles that explore various aspects of the gut virome, with a particular focus on, but not limited to, the following themes:
- Gut virome dysbiosis in diseases.
- Efficacy and safety of fecal virome transplantation or phage therapy.
- Spatial distribution of viruses and virus–host interactions.
- Systematic review and/or meta-analysis on generalizable virome biomarkers.
Through the collective contributions of this Special Issue, we aim to advance our understanding of the gut virome's role in health and diseases, shed light on the potential of fecal virome transplantation and phage therapy, and identify virome biomarkers for clinical applications. The interdisciplinary nature of this topic encourages engagement from researchers and practitioners in fields such as virology, microbiology, immunology, gastroenterology, and clinical medicine.
Dr. Ye Peng
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut virome
- fecal virome transplantation
- phage therapy
- microecological regulation
- viral dark matter
